Match!
Wenya Yang
13Publications
6H-index
355Citations
Publications 13
Newest
#1Wenya YangH-Index: 6
#2Timothy M. Dall (IHS Inc.)H-Index: 16
Last.F. Ellen Loh (UMB: University of Maryland, Baltimore)H-Index: 5
view all 7 authors...
Abstract This study provides diabetes-related metrics for the 50 largest metropolitan areas in the U.S. in 2012—including prevalence of diagnosed and undiagnosed diabetes, insurance status of the population with diabetes, diabetes medication use, and prevalence of poorly controlled diabetes. Diabetes prevalence estimates were calculated using cross-sectional data combining the Behavioral Risk Factor Surveillance System, American Community Survey, National Nursing Home Survey, Census population f...
Source
#1Wenya YangH-Index: 6
Last.Kimberly J. Elenberg (USPHS: United States Public Health Service)H-Index: 1
view all 7 authors...
Source
#1Eleonora TanH-Index: 1
#2Wenya YangH-Index: 6
Last.Paul F HoganH-Index: 1
view all 6 authors...
BACKGROUND: Medication nonadherence is an imperative public health concern. Among patients with type 2 diabetes mellitus (T2DM), poor adherence to antidiabetic agents is strongly associated with suboptimal glycemic control. Poor adherence and hyperglycemia greatly increase diabetes-related morbidity and mortality. At a national level, diabetes drug adherence using average proportion of days covered (PDC) is estimated to range between 36% and 81%, with an estimated range for diabetes control betw...
5 CitationsSource
#1Timothy M. Dall (IHS Inc.)H-Index: 16
#2Wenya YangH-Index: 6
Last.Paul F. HoganH-Index: 7
view all 9 authors...
OBJECTIVE To update estimates of the economic burden of undiagnosed diabetes, prediabetes, and gestational diabetes mellitus in 2012 in the U.S. and to present state-level estimates. Combined with published estimates for diagnosed diabetes, these statistics provide a detailed picture of the economic costs associated with elevated glucose levels. RESEARCH DESIGN AND METHODS This study estimated health care use and medical expenditures in excess of expected levels occurring in the absence of diabe...
132 CitationsSource
#1Anjali JainH-Index: 1
#2Donna L SpencerH-Index: 2
Last.Taylor DennenH-Index: 2
view all 10 authors...
Abstract Objective We compared risk of injury among children with autism spectrum disorder (ASD) to those without ASD, adjusting for demographic and clinical characteristics. Methods We used claims data from 2001 to 2009 from a commercial health plan in the United States. A validated ASD case identification algorithm identified 33,565 children (ages 0–20 years) with ASD and 138,876 children without. Counting process models tested the association between ASD status and injury episodes with separa...
13 CitationsSource
#1James P BurkeH-Index: 1
#2Anjali JainH-Index: 11
Last.Craig J. NewschafferH-Index: 48
view all 8 authors...
The purpose of this study was to validate autism spectrum disorder cases identified through claims-based case identification algorithms against a clinical review of medical charts. Charts were reviewed for 432 children who fell into one of the three following groups: (a) more than or equal to two claims with an autism spectrum disorder diagnosis code (n = 182), (b) one claim with an autism spectrum disorder diagnosis code (n = 190), and (c) those who had no claims for autism spectrum disorder bu...
48 CitationsSource
#1Jane Larkindale (Muscular Dystrophy Association)H-Index: 2
#2Wenya YangH-Index: 6
Last.Valerie Cwik (Muscular Dystrophy Association)H-Index: 13
view all 9 authors...
Introduction: We conducted a comprehensive study of the costs associated with amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD). and myotonic dystrophy (DM) in the U.S. Methods: We determined the total impact on the U.S. economy, including direct medical costs, nonmedical costs, and loss of income. Medical costs were calculated using a commercial insurance database and Medicare claims data. Nonmedical and indirect costs were determined through a survey of families registered...
57 CitationsSource
#1Jane Larkindale (Muscular Dystrophy Association)H-Index: 2
#2Wenya YangH-Index: 6
Last.Valerie Cwik (Muscular Dystrophy Association)H-Index: 13
view all 9 authors...
2 Citations
#1Wenya YangH-Index: 6
#2James H. WilliamsH-Index: 2
Last.Michael GoldsteinH-Index: 18
view all 11 authors...
Anticipated oncologist shortages are largely consistent with the ASCO 2007 workforce study but somewhat more delayed. The ACA may exacerbate the shortage.
74 CitationsSource
#1Wenya YangH-Index: 6
#2Timothy M. Dall (IHS Inc.)H-Index: 16
Last.Anjali JainH-Index: 5
view all 7 authors...
Despite the documented benefits of quitting smoking, studies have found that smokers who quit may have higher lifetime medical costs, in part because of increased risk for medical conditions, such as type 2 diabetes, brought on by associated weight gain. Using a simulation model and data on 612,332 adult smokers in the US Department of Defense’s TRICARE Prime health plan in 2008, we estimated that cessation accompanied by weight gain would increase average life expectancy by 3.7 years, and that ...
6 CitationsSource
12